Fred Grossman

Fred Grossman

President, Chief Medical OfficeratCoya Therapeutics· In proxies 2022–2025

Pay in FY2025-23% from the year before · Coya Therapeutics stock +1.2% the same year

Fred Grossman was paid $1.5M in FY2025 (Dec), down 23%. Coya Therapeutics stock rose 1.2% that year.

Pay$100 in the stock at the end of FY22 → $122
Pay is from the Summary Compensation Table of each Coya Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Coya TherapeuticsPublic company · 4 yr
    • President, Chief Medical Officer2022 – Present · 4 yrStock in role -14%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?